Organigram Announces Appointment of Craig Harris to Board of Directors
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has appointed Craig Harris to its Board of Directors, expanding the board to 10 members. Harris, currently the Assistant General Counsel at British American Tobacco plc (BAT), brings over 20 years of experience as a commercial lawyer. His expertise includes corporate law, regulatory engagement, and major global projects.
Harris has contributed to significant BAT initiatives, including the $49 billion merger with Reynolds American Inc. and the establishment of BAT's partnership with the McLaren Formula 1 team. He serves on several BAT company boards and is part of the Investment Committee for Btomorrow Ventures, BAT's venture capital arm. Harris's achievements have been recognized by Legal 500 UK, naming him UK Mergers & Acquisitions Individual of the Year in 2018.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) ha nominato Craig Harris nel suo Consiglio di Amministrazione, ampliando il consiglio a 10 membri. Harris, attualmente Assistente Consigliere Generale presso British American Tobacco plc (BAT), porta con sé oltre 20 anni di esperienza come avvocato commerciale. La sua expertise comprende diritto societario, rapporti normativi e grandi progetti globali.
Harris ha contribuito a iniziative significative di BAT, inclusa la fusione da 49 miliardi di dollari con Reynolds American Inc. e la creazione della partnership di BAT con il team di Formula 1 McLaren. Fa parte di diversi consigli di amministrazione di BAT ed è membro del Comitato di Investimento per Btomorrow Ventures, il braccio di venture capital di BAT. I risultati di Harris sono stati riconosciuti dal Legal 500 UK, che lo ha nominato Individuale dell'Anno per Fusioni e Acquisizioni nel Regno Unito nel 2018.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) ha designado a Craig Harris en su Junta Directiva, ampliando la junta a 10 miembros. Harris,actualmente Asistente del Consejero General en British American Tobacco plc (BAT), aporta más de 20 años de experiencia como abogado comercial. Su experiencia incluye derecho corporativo, relación regulatoria y grandes proyectos globales.
Harris ha contribuido a iniciativas significativas de BAT, incluida la fusión de 49 mil millones de dólares con Reynolds American Inc. y el establecimiento de la asociación de BAT con el equipo de Fórmula 1 McLaren. Se desempeña en varias juntas de empresas de BAT y es parte del Comité de Inversiones de Btomorrow Ventures, el brazo de capital de riesgo de BAT. Los logros de Harris han sido reconocidos por Legal 500 UK, nombrándolo Individual del Año en Fusiones y Adquisiciones en el Reino Unido en 2018.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI)가 이사회에 Craig Harris를 임명했습니다, 이사회는 총 10명으로 확대되었습니다. Harris는 현재 British American Tobacco plc (BAT)에서 보조 법률고문으로 활동하고 있으며, 20년 이상의 상업 변호사 경험을 보유하고 있습니다. 그의 전문 분야는 기업법, 규제 대응 및 대규모 글로벌 프로젝트입니다.
Harris는 BAT의 주요 이니셔티브에 기여했으며, Reynolds American Inc.와의 490억 달러 규모의 합병과 BAT와 McLaren 포뮬러 1 팀 간의 파트너십 수립 등이 포함됩니다. 그는 여러 BAT 자회사 이사회에 참석하고 있으며, BAT의 벤처 캐피탈 부서인 Btomorrow Ventures의 투자 위원회에도 소속되어 있습니다. Harris의 성과는 Legal 500 UK에서 인정받았으며, 2018년에 영국 인수합병 개인으로 선정되었습니다.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) a nommé Craig Harris à son Conseil d'Administration, portant le nombre de membres à 10. Harris, actuellement Conseiller Général Adjoint chez British American Tobacco plc (BAT), possède plus de 20 ans d'expérience en tant qu'avocat en affaires. Son expertise comprend le droit des sociétés, l'engagement réglementaire et de grands projets mondiaux.
Harris a contribué à des initiatives importantes de BAT, notamment à la fusion de 49 milliards de dollars avec Reynolds American Inc. et à l'établissement du partenariat entre BAT et l'équipe McLaren de Formule 1. Il siège dans plusieurs conseils d'administration d'entreprises de BAT et fait partie du Comité d'Investissement de Btomorrow Ventures, le bras de capital-risque de BAT. Les réalisations de Harris ont été reconnues par Legal 500 UK, qui l'a nommé Individu de l'Année en Fusions et Acquisitions au Royaume-Uni en 2018.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) hat Craig Harris in seinen Vorstand berufen und damit den Vorstand auf 10 Mitglieder erweitert. Harris ist derzeit als Assistenzgeneralrechtsanwalt bei British American Tobacco plc (BAT) tätig und bringt mehr als 20 Jahre Erfahrung als Wirtschaftsrechtler mit. Seine Expertise umfasst Unternehmensrecht, regulatorische Zusammenarbeit und bedeutende globale Projekte.
Harris hat zu wichtigen BAT-Initiativen beigetragen, einschließlich der 49 Milliarden Dollar schweren Fusion mit Reynolds American Inc. und der Einrichtung der Partnerschaft von BAT mit dem Formel-1-Team McLaren. Er sitzt in mehreren Unternehmensvorständen von BAT und ist Mitglied des Investitionsausschusses von Btomorrow Ventures, dem Venture-Capital-Zweig von BAT. Harris' Leistungen wurden von Legal 500 UK anerkannt, das ihn 2018 zum britischen Mergers & Acquisitions Individual of the Year ernannte.
- Appointment of experienced corporate lawyer Craig Harris to the Board of Directors
- Harris brings expertise in regulatory engagement and major global projects
- Harris's involvement in BAT's $49 billion merger with Reynolds American Inc. demonstrates high-level transaction experience
- Recognition by Legal 500 UK as UK Mergers & Acquisitions Individual of the Year in 2018
- None.
Craig Harris (Photo: Business Wire)
"We are thrilled to welcome Craig to our Board of Directors as BAT’s third nominee bringing the number of directors to 10. His extensive experience in corporate law, regulatory engagement, and major global projects, including his impactful work at BAT, will be invaluable to our strategic growth. Craig's proven leadership and expertise make him a remarkable addition to our Board," said Peter Amirault, Board Chair, Organigram.
In his role at BAT, Craig has contributed to a range of significant projects, including BAT’s USD
Craig’s achievements have been recognized by the Legal 500 UK, which included him in their General Counsel Power list for 2023 and named him the
About Organigram
Organigram is a NASDAQ Global Select Market and TSX listed company whose primary wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis-derived products and cannabis-infused edibles in
Organigram is focused on producing high-quality, cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates cultivation and manufacturing facilities in
Forward-Looking Information
This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.
Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240729497569/en/
For Media enquiries:
Megan McCrae
Senior Vice President of Global Brands and Corporate Affairs
megan.mccrae@organigram.ca
For Investor Relations enquiries:
Max Schwartz
Director of Investor Relations
investors@organigram.ca
Source: Organigram Holdings Inc.
FAQ
Who is the new Board member appointed by Organigram (OGI)?
What experience does Craig Harris bring to Organigram's (OGI) Board?
How many members are now on Organigram's (OGI) Board of Directors?
What recognition has Craig Harris received in his legal career?
